CAMBRIDGE, Mass.--(BUSINESS WIRE)--Epizyme, Inc. (NASDAQ: EPZM), a clinical stage biopharmaceutical company creating novel epigenetic therapies for people with cancer, announced today that management will host a conference call and live audio webcast on Monday, May 9, 2016, at 8:00 a.m. Eastern Time to report first quarter 2016 financial results and provide a corporate update. In addition, the company will be participating in two investor conferences in the month of May, Bank of America Merrill Lynch 2016 Health Care Conference and the UBS Global Health Care Conference.
